Hypermethylation-Associated Silencing of miR-125a and miR-125b: A Potential Marker in Colorectal Cancer

Abstract EN

Background.

MicroRNAs (miRNAs) have been found to be downregulated in human colorectal cancer (CRC), and some of them may function as tumor suppressor genes (TSGs).

Aberrant methylation triggers the inactivation of TSGs during tumorigenesis.

Patients and Methods.

We investigated the methylation status of miR-125 family in CRC tissues and adjacent nontumor tissues by using bisulfite sequencing PCR (BSP).

The expression levels of the two miRNAs were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR).

Results.

The methylation frequency of miR-125a and miR-125b was higher in CRC tissues.

QRT-PCR analysis showed that miR-125a and miR-125b were significantly downregulated in CRC tissues.

Moreover, the expression levels of miR-125a and miR-125b were inversely correlated to CpG island methylation in CRC.

Conclusions.

Our results suggest that DNA hypermethylation may be involved in the inactivation of miR-125a and miR-125b in CRC, and hypermethylation of miR-125 is a potential biomarker for clinical outcome.